Cutaneous Amebiasis

Cutaneous Amebiasis: Intro - Amebic Invader Alert

• What: A rare, aggressive parasitic infection of the skin.
• Invader: Caused by the protozoan Entamoeba histolytica, primarily its trophozoite form.
• Invasion Routes:
  • Direct skin inoculation (e.g., trauma, surgery).
  • Extension from deeper amebic foci (e.g., liver abscess, intestinal disease).
  • Hematogenous spread (less common).
• Red Flag: Its presence often indicates severe underlying visceral amebiasis or compromised immunity.
• Typically presents as painful, rapidly destructive ulcers.

⭐ Cutaneous amebiasis is a rare but severe extraintestinal manifestation of Entamoeba histolytica infection, often indicating underlying visceral involvement or direct inoculation.

Cutaneous Amebiasis: Clinical Signs - Skin's Sore Story

• Onset: Often a painful papule/pustule.
• Evolution: Rapid progression to ulcer with significant tissue destruction.
• Ulcer Features:
  • Edges: Sharply defined, raised, violaceous, undermined ("cliff-edge").
  • Base: Necrotic debris, pus, or blood-tinged, foul-smelling exudate.
  • Shape: Irregular, serpiginous, or amoeboid.
  • Surrounding: Erythema, edema.
• Hallmark Symptom: Severe, persistent pain, often disproportionate to lesion size.
• Predilection Sites:
  • Perianal, perineal, genital (most common; direct extension/autoinoculation).
  • Abdominal wall (post-surgery for amoebic liver abscess, colostomies).
  • Less common: Buttocks, legs, face.
• Systemic: Fever, malaise, weight loss possible with extensive disease.
• Rare: Amebiasis cutis anserina (follicular papules like gooseflesh).

⭐ The characteristic lesion is a rapidly progressive, painful ulcer with undermined, ragged edges and a necrotic, often blood-tinged, base.

Cutaneous Amebiasis: Diagnosis - Spotting the Culprit

• Primary Goal: Identify Entamoeba histolytica trophozoites.
• Key Samples: Scrapings/aspirates from ulcer edge; Biopsy from active ulcer margin.

• Microscopy:
  • Wet mount (saline/iodine): Look for motile trophozoites, often with ingested RBCs (erythrophagocytosis).
• Histopathology (Biopsy):
  • Key for demonstrating tissue invasion.
  • Shows characteristic flask-shaped ulcers, necrosis, inflammation.
  • Trophozoites found at the junction of necrotic & viable tissue; PAS stain can highlight them.

⭐ Definitive diagnosis relies on demonstrating E. histolytica trophozoites (often containing ingested RBCs) in tissue biopsy or scrapings from the ulcer edge.

• Culture:
  • Specialized media (e.g., Robinson's medium). Generally low sensitivity.
• PCR (Polymerase Chain Reaction):
  • Highly sensitive & specific for E. histolytica DNA.
  • Differentiates pathogenic E. histolytica from non-pathogenic E. dispar.
• Serology:
  • Detects anti-amebic antibodies (IgG).
  • More reliable for systemic amebiasis (e.g., liver abscess); supportive in cutaneous cases.

Cutaneous Amebiasis: Management - Kicking Out Amebae

• Goal: Eradicate Entamoeba histolytica & promote healing.
• Systemic Therapy:

  ⭐ Systemic metronidazole (e.g., 750 mg TID for 7-10 days) is the mainstay of treatment, combined with management of any underlying intestinal or hepatic amebiasis.

  • Alternatives: Tinidazole (2g OD for 3 days).
• Luminal Amebicides (Post-Systemic Therapy):
  • Purpose: Eliminate intestinal carriage, prevent relapse.
  • Agents: Paromomycin, iodoquinol, diloxanide furoate.
• Surgical Intervention (Adjunctive):
  • Debridement: For extensive necrotic tissue.
  • Drainage: For associated abscesses.
• Supportive Care:
  • Wound management.
  • Nutritional support.
  • Pain relief.
• Prevention: Improve personal hygiene; screen & treat asymptomatic carriers/contacts.

High‑Yield Points - ⚡ Biggest Takeaways

• Caused by Entamoeba histolytica, often secondary to intestinal/hepatic amebiasis.
• Presents as painful, rapidly progressive ulcers with undermined edges and necrotic, "gun-metal gray" base.
• Flask-shaped ulcers are characteristic on biopsy.
• Common sites include perianal, genital regions, and abdominal wall (e.g., post-surgery).
• Diagnosis via trophozoites in biopsy or exudate.
• Treatment: Systemic metronidazole is key; surgical debridement may be required.
• Can lead to fistulae and secondary bacterial infections.